Misplaced Pages

3,4-Ethylenedioxymethcathinone

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from EDMC (drug)) Pharmaceutical compound
3,4-Ethylenedioxymethcathinone
Clinical data
Other namesEDMC; Ethylenedioxymethcathinone; 3,4-Ethylenedioxy-N-methylcathinone; β-Keto-EDMA; BK-EDMA; βk-EDMA
Drug classSerotonin–norepinephrine–dopamine releasing agent
Identifiers
IUPAC name
  • 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(methylamino)propan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC12H15NO3
Molar mass221.256 g·mol
3D model (JSmol)
SMILES
  • CC(C(=O)C1=CC2=C(C=C1)OCCO2)NC
InChI
  • InChI=1S/C12H15NO3/c1-8(13-2)12(14)9-3-4-10-11(7-9)16-6-5-15-10/h3-4,7-8,13H,5-6H2,1-2H3
  • Key:MRFMNGZRIIBJTB-UHFFFAOYSA-N

3,4-Ethylenedioxymethcathinone (EDMC), or 3,4-ethylenedioxy-N-methylcathinone, is a monoamine releasing agent (MRA) of the cathinone family related to methylone (3,4-methylenedioxymethcathinone; MDMC). It is the β-keto or cathinone analogue of 3,4-ethylenedioxymethamphetamine (EDMA).

EDMC acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA). Its EC50Tooltip half-maximal effective concentration values for induction of monoamine release are 347 nM for serotonin, 327 nM for norepinephrine, and 496 nM for dopamine in rat brain synaptosomes. These potencies were about 1.4-fold, 2.2-fold, and 3.7-fold lower than those of methylone, respectively.

The drug was first described in 2015, whereas EDMA has been described much earlier.

See also

References

  1. ^ Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA (September 2015). "Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine". Bioorg Med Chem. 23 (17): 5574–5579. doi:10.1016/j.bmc.2015.07.035. PMC 4562428. PMID 26233799.
  2. ^ Sakloth, Farhana (11 December 2015). "Psychoactive synthetic cathinones (or 'bath salts'): Investigation of mechanisms of action". VCU Scholars Compass. Retrieved 19 January 2025.
  3. ^ Glennon RA, Dukat M (2017). "Structure-Activity Relationships of Synthetic Cathinones". Curr Top Behav Neurosci. Current Topics in Behavioral Neurosciences. 32: 19–47. doi:10.1007/7854_2016_41. ISBN 978-3-319-52442-9. PMC 5818155. PMID 27830576. Expansion of the methylenedioxy ring of methylone (24) to an ethylenedioxy ring (i.e., ethylenedioxymethcathinone, EDMC; 30; Figure 7) decreased its potency as a releasing agent at all three transporters by 2- to 3-fold (Del Bello et al., 2015).
  4. Yadav, Barkha J (16 July 2019). Understanding Structure–Activity Relationship of Synthetic Cathinones (Bath Salts) Utilizing Methylphenidate. VCU Scholars Compass (Thesis). doi:10.25772/MJQW-8C64. Retrieved 24 November 2024. 8 In another study conducted by Del Bello et al.89 it was found that expansion of the methylenedioxy ring of MDMC (27) to an ethylenedioxy ring (EDMC, 31, Figure 14) slightly reduced its potency as a releasing agent at all three transporters.


Empathogens/entactogens
Phenylalkyl-
amines

(other than
cathinones)
Cyclized phenyl-
alkylamines
Cathinones
Tryptamines
Chemical classes
Monoamine releasing agents
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
See also: Receptor/signaling modulatorsMonoamine reuptake inhibitorsAdrenergicsDopaminergicsSerotonergicsMonoamine metabolism modulatorsMonoamine neurotoxins
Phenethylamines
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines
(and close relatives)
Miscellaneous


Stub icon

This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
3,4-Ethylenedioxymethcathinone Add topic